ClinicalTrials.Veeva

Menu

Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants

The University of Texas System (UT) logo

The University of Texas System (UT)

Status and phase

Completed
Phase 3
Phase 2

Conditions

Anemia

Treatments

Drug: Iron Supplement
Drug: control

Study type

Interventional

Funder types

Other

Identifiers

NCT01224236
RCT of Iron Supplementation

Details and patient eligibility

About

The purpose of this study is to determine if iron supplementation in addition to routine iron intake decreases the risk of developing anemia in preterm infants.

Full description

Objective was to determine if iron supplementation of 2 mg/kg per day, in addition to routine iron-fortified formula or mother's milk, increased the hematocrit (Hct) at 36 weeks' postmenstrual age (PMA).

All infants have a decline in hemoglobin(Hgb) after birth because of increasing PaO2 and Hgb saturation after birth. In very low birth weight (VLBW) infants (birth weight ,1500 g), the nadir at 1 to 3 months after birth is lower than in term infants because of (1) greater phlebotomy losses for blood tests, (2) shortened red blood cell survival, and (3)rapid growth.

VLBW infants may be at increased risk of developing iron deficiency anemia because of (1) low iron stores at birth, (2) rapid depletion of iron stores owing to phlebotomy losses, and (3) inability to regulate iron absorption by the gastrointestinal tract.

Enrollment

150 patients

Sex

All

Ages

Under 8 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. birth weight: < 1500 grams
  2. Tolerating iron fortified preterm formula or fortified breast milk at 120cc/kg/day by 8 weeks of age
  3. ≤32 weeks adjusted post-menstrual age at the time of enrollment

Exclusion criteria

  1. cyanotic heart disease
  2. bowel resection prior to enrollment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

150 participants in 2 patient groups

iron supplementation
Experimental group
Description:
2 mg/kg/day of elemental iron as a multivitamin with iron solution
Treatment:
Drug: Iron Supplement
control
Sham Comparator group
Description:
multivitamin solution without iron
Treatment:
Drug: control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems